Marisa Jaconi

Calreticulin reveals a critical Ca(2+) checkpoint in cardiac myofibrillogenesis.

Embryonic stem cells: new possible therapy for degenerative diseases that affect elderly people.

Cardiac tissue engineering: regeneration of the wounded heart.

Ca2+ signalling in cardiogenesis.

Rapid generation of stable transgenic embryonic stem cell lines using modular lentivectors.

The NADPH oxidase NOX4 drives cardiac differentiation: Role in regulating cardiac transcription factors and MAP kinase activation.

Expression and function of alpha-smooth muscle actin during embryonic-stem-cell-derived cardiomyocyte differentiation.

Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach.

Fetal bovine serum enables cardiac differentiation of human embryonic stem cells.

Xeno-free derivation and culture of human embryonic stem cells: current status, problems and challenges.

[MR imaging of embryonic stem cells labeled by superparamagnetic iron oxide].

Fate of undifferentiated mouse embryonic stem cells within the rat heart: role of myocardial infarction and immune suppression.

Three-dimensional extracellular matrix-directed cardioprogenitor differentiation: systematic modulation of a synthetic cell-responsive PEG-hydrogel.

Derivation of the first Swiss human embryonic stem cell line from a single blastomere of an arrested four-cell stage embryo.

Immortalized human skin fibroblast feeder cells support growth and maintenance of both human embryonic and induced pluripotent stem cells.

Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in mice.

Pluripotent stem cells as new drugs? The example of Parkinson's disease.

A teratocarcinoma-like human embryonic stem cell (hESC) line and four hESC lines reveal potentially oncogenic genomic changes.

Transplantation of mouse embryonic stem cells induces hematopoietic and tissue chimerism in rats.

Human pluripotent stem cells differentiated in fully defined medium generate hematopoietic CD34- and CD34+ progenitors with distinct characteristics.

Nanomedicine: Gold nanowires to mend a heart.

Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage.

The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity.

High-speed tracking of murine cardiac stem cells by harmonic nanodoublers.

Mathematical modelling of the action potential of human embryonic stem cell derived cardiomyocytes.

Embryonic stem cell-based cardiopatches improve cardiac function in infarcted rats.

Molecular and functional evidence of HCN4 and caveolin-3 interaction during cardiomyocyte differentiation from human embryonic stem cells.

Human stem cell-based three-dimensional microtissues for advanced cardiac cell therapies.